117 related articles for article (PubMed ID: 8361218)
1. Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantation.
Storb R
Leukemia; 1993 Aug; 7 Suppl 2():S135-7. PubMed ID: 8361218
[No Abstract] [Full Text] [Related]
2. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Buckner CD; Clift RA; Appelbaum FR; Storb R; Petersen FB; Sanders JE; Thomas ED; Hansen JA
Bone Marrow Transplant; 1991; 7 Suppl 2():6-8. PubMed ID: 1878723
[No Abstract] [Full Text] [Related]
3. The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
Frassoni F; Bacigalupo A; Sessarego M; Gualandi F; Lamparelli T; Van Lint MT; Occhini D; Corvò R; Scarpati D; Vitale V
Bone Marrow Transplant; 1991; 7 Suppl 2():130. PubMed ID: 1878675
[No Abstract] [Full Text] [Related]
4. Non-supralethal mitobronitol/cytarabine/cyclophosphamide conditioning without irradiation before bone marrow transplantation for accelerated chronic granulocytic leukemia: apparent absence of acute graft-versus-host disease.
Kelemen E; Jakab K; Váradi G; Jánossa M; Földi J; Dénes R
Leukemia; 1993 Jul; 7(7):939-45. PubMed ID: 8321045
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia treated by allogeneic bone marrow transplantation.
Szer J; Sheridan WP
Transplant Proc; 1992 Feb; 24(1):181-2. PubMed ID: 1539235
[No Abstract] [Full Text] [Related]
6. [Bone marrow transplantation for chronic myelogenous leukemia].
Imanari A; Shibata A
Nihon Rinsho; 1990 Sep; 48(9):2087-91. PubMed ID: 2232214
[No Abstract] [Full Text] [Related]
7. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
[No Abstract] [Full Text] [Related]
8. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
Champlin R; Jansen J; Ho W; Gajewski J; Nimer S; Lee K; Territo M; Winston D; Tricot G; Reichert T
Transplant Proc; 1991 Feb; 23(1 Pt 2):1695-6. PubMed ID: 1899162
[No Abstract] [Full Text] [Related]
9. [Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors].
Brinch L; Evensen SA; Albrechtsen D; Egeland T; Solheim BG; Rollag H; Naalsund A; Jacobsen AB
Tidsskr Nor Laegeforen; 1991 Jan; 111(3):311-5. PubMed ID: 2000610
[TBL] [Abstract][Full Text] [Related]
10. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
11. Effects of treatment regimens on post marrow transplant relapse.
Buckner CD; Clift RA; Appelbaum FR; Storb R; Fefer A; Petersen FB; Sanders JE; Sullivan K; Thomas ED; Hansen JA
Semin Hematol; 1991 Jul; 28(3 Suppl 4):32-4. PubMed ID: 1780749
[No Abstract] [Full Text] [Related]
12. Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group.
Kolb HJ; Bender-Götze C; Haas RJ; Holler E; Thierfelder S; Wilmanns W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):397-402. PubMed ID: 2480280
[TBL] [Abstract][Full Text] [Related]
13. Interstitial pneumonitis after allogeneic bone marrow transplantation following total body irradiation.
Kurisu K; Taniguchi M; Kamikonya N; Hishikawa Y; Miura T; Inoue N; Kanamaru A; Kakishita E; Kai S; Hara H
Radiat Med; 1991; 9(3):118-21. PubMed ID: 1656487
[TBL] [Abstract][Full Text] [Related]
14. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO).
Socie G; Devergie A; Girinsky T; Reiffers J; Vernant JP; Le Bourgeois JP; Herve P; Guyotat D; Maraninchi D; Rio B
Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):397-404. PubMed ID: 1995523
[TBL] [Abstract][Full Text] [Related]
15. Use of an anti-interleukine 2 receptor monoclonal antibody for GvHD prophylaxis in unrelated bone marrow transplantation. GEGMO Group.
Belanger C
Bone Marrow Transplant; 1993; 11 Suppl 1():112-3. PubMed ID: 8448532
[No Abstract] [Full Text] [Related]
16. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
17. [The allograft in chronic myeloid leukemia].
Arcese W; Mauro FR; Screnci M; Iori AP; Papa G; Mandelli F
Haematologica; 1989 Oct; 74(5 Suppl):443-59. PubMed ID: 2512228
[No Abstract] [Full Text] [Related]
18. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
19. Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia.
Horwitz LJ; Kantarjian HM; Jagannath S; Keating MJ; McCredie KB; Spitzer G; Vellekoop L; Zander AR; Dicke KA
Bone Marrow Transplant; 1989 Jan; 4(1):101-5. PubMed ID: 2647172
[TBL] [Abstract][Full Text] [Related]
20. A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
Henslee PJ; Byers VS; Jennings CD; Marciniak E; Thompson JS; Macdonald JS; Romond EH; Messino MJ; Scannon PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3004-7. PubMed ID: 2650413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
